|
Market Closed -
Xetra
19:35:32 09/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.660 EUR | +0.87% |
|
-0.43% | -19.66% |
| 09-17 | Novo, Orbis sign up to $1.4 billion deal to develop oral drugs | RE |
| 08-20 | ORBIS AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Stocks
- OBS Stock
- Consensus ORBIS AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
